DocumentCode
2177193
Title
Drug Design for AMP-Activated Protein Kinase Agonists in Silico
Author
Chen, Chien-Yu ; Bau, Da-Tian ; Tsai, Ming-Hsui ; Hsu, Yuan-Man ; Ho, Tin-Yun ; Huang, Hung-Jin ; Chang, Yea-Huey ; Tsai, Fuu-Jen ; Tsai, Chang-Hai ; Chen, Calvin Yu-Chian
Author_Institution
Dept. of Biol. Sci. & Technol., China Med. Univ., Taichung, Taiwan
fYear
2009
fDate
17-19 Oct. 2009
Firstpage
1
Lastpage
4
Abstract
AMP-activated protein kinase (AMPK) is a metabolite- sensed protein kinase in various eukaryotes. The activated AMPK regulates important proteins which cause diabetes, obesity, metabolic aberrant, and also breast cancer. In this study, the yeast AMPK structure was used as a template to model the human AMPK structure. By homology modeling, the reliable AMPK structure was built, and the active binding site was defined corresponding to X-ray crystal structure of yeast AMPK By virtual screening the database. All the potent ligands had the H-bond interaction in the key residues, same as the control. Thus, we suggested the phenylamide derivates might be the potent AMPK agonists.
Keywords
diseases; drugs; enzymes; molecular biophysics; molecular configurations; AMP-activated protein kinase agonists; H-bond interaction; X-ray crystal structure; breast cancer; diabetes; drug design; homology modeling; human AMPK structure; metabolic aberrant; metabolite-sensed protein kinase; obesity; phenylamide derivates; potent ligands; silico; virtual screening; yeast AMPK structure; Amino acids; Asia; Diabetes; Drugs; Fungi; Hospitals; Humans; Laboratories; Proteins; Sugar;
fLanguage
English
Publisher
ieee
Conference_Titel
Biomedical Engineering and Informatics, 2009. BMEI '09. 2nd International Conference on
Conference_Location
Tianjin
Print_ISBN
978-1-4244-4132-7
Electronic_ISBN
978-1-4244-4134-1
Type
conf
DOI
10.1109/BMEI.2009.5304901
Filename
5304901
Link To Document